Rocket


Overview
Financials
News + Filings

 
 

QLY Biotech Group Corp. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsAug-31-22Aug-31-21Aug-31-20
Revenues0.00.00.0
            Revenue growth-100.0%0.0% 
Cost of goods sold0.00.00.0
Gross profit0.00.00.0
            Gross margin 65.0%65.0%
General and administrative0.00.00.0
EBITA0.00.00.0
            EBITA margin -627.6%-298.3%
Amortization of intangibles0.00.00.0
EBIT0.00.00.0
            EBIT margin -667.6%-331.6%
Pre-tax income0.00.00.0
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income0.00.00.0
            Net margin -737.6%-133.3%
 
Diluted EPS$0.00($0.01)$0.00
Shares outstanding (diluted)3.93.93.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy